voclosporin
Voclosporin is a synthetic immunosuppressant medication used to prevent organ rejection in patients who have undergone organ transplantation. It is a calcineurin inhibitor, similar to cyclosporine, but with a different chemical structure. Voclosporin works by inhibiting the calcineurin pathway, which is involved in the activation of T cells, a type of white blood cell that plays a crucial role in the immune response. By blocking this pathway, voclosporin helps to reduce the body's immune response against the transplanted organ, thereby decreasing the risk of rejection.
Voclosporin is available in tablet form and is typically taken orally. It is usually prescribed in combination
Voclosporin was approved for medical use in the United States in 2003 and is marketed under the